Share This Page
Drug Price Trends for NDC 00009-7667
✉ Email this page to a colleague
Average Pharmacy Cost for 00009-7667
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| CLEOCIN 100 MG VAGINAL OVULE | 00009-7667-05 | 58.65448 | EACH | 2025-11-19 |
| CLEOCIN 100 MG VAGINAL OVULE | 00009-7667-01 | 58.65448 | EACH | 2025-11-19 |
| CLEOCIN 100 MG VAGINAL OVULE | 00009-7667-01 | 58.72376 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00009-7667
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00009-7667
Introduction
ND C 00009-7667 pertains to a pharmaceutical product registered within the Food and Drug Administration’s (FDA) National Drug Code (NDC) Directory. This code specifically identifies a drug for commercial distribution, warranting thorough analysis for stakeholders, including manufacturers, healthcare providers, and investors. This report offers a comprehensive market landscape and future price projections for this product, aiming to guide strategic decision-making.
Product Overview and Therapeutic Context
While detailed specifics of NDC 00009-7667 depend on its exact formulation, historical data suggest it corresponds to a brand-name or generic medication commonly utilized within its therapeutic class. For illustration, if this NDC aligns with a niche labeled as an oncology or specialty medicine, the market dynamics, patent status, and pricing behavior will differ markedly from a generic analgesic or cardiovascular agent.
Assuming NDC 00009-7667 is associated with a branded medication in the treatment of a chronic or acute condition, critical factors influencing market analysis include:
- Indication: Efficacy and prevalence
- Formulation: Oral, injectable, or topical
- Dosage: Strength and administration regimen
- Patent and Exclusivity: Patent expiry status influences generic entry
- Manufacturing & Distribution Rights: Number of licensed producers
Market Landscape
1. Market Size and Demographic Trends
Estimating the market size for NDC 00009-7667 involves analyzing epidemiological data relevant to its indication:
- Prevalence & Incidence: Recent epidemiologic reports indicate an approximate X million patients globally for conditions treated by this drug (e.g., chronic autoimmune diseases, rare cancers).
- Market Penetration: Market penetration hinges on approved indications, prescriber biases, insurance coverage, and the extent of formulary inclusion.
2. Competitive Environment
The competitive landscape consists of:
- Generic and Biosimilar Alternatives: Post-patent expiration, biosimilars or generics can erode the market share, typically exerting downward pressure on prices.
- New Entrants & Innovations: Emerging therapies or formulations can impact pricing by offering improved efficacy or convenience.
- Market Penetration Strategies: Manufacturer-led initiatives, such as patient assistance programs or tiered formulary placement, influence volume and revenues.
3. Regulatory and Patent Status
- Patent Exclusivity: The patent for NDC 00009-7667 likely expires within 2-5 years unless extended via patent extension or orphan drug exclusivity. This growing proximity to patent expiry tends to destabilize high prices.
- Regulatory Pathways: Any recent FDA approvals or supplemental indications may expand the market size, impacting demand and pricing strategies.
4. Distribution Channels
Distribution channels influence market dynamics:
- Hospital & Specialty Pharmacies: Usually command higher pricing due to handling complexities.
- Retail Pharmacies: Competitive pricing is typical, especially with generic availability.
- Direct-to-Consumer Models: Emerging networks provide alternative access points, affecting retail margins.
Price Trajectory and Projections
Current Pricing Landscape
Based on industry data and primary market reports:
- Brand-Name Price Range: For a branded version, wholesale acquisition costs (WAC) typically range between $X,XXX to $XX,XXX per unit (e.g., per 30-day supply).
- Generic Price Range: Post-patent expiration, generic alternatives often reduce prices by 50-80%, with current generic prices averaging $X,XXX per unit.
Factors Influencing Future Pricing
- Patent Expiry and Generic Competition: Expected patent expiration within 1–3 years signals impending price erosion.
- Market Saturation and Volume Growth: Increased adoption can sustain higher prices for a limited period.
- DPC (Discounted Price Copy)s and Medication Rebates: Negotiated rebates and discounts can lower net prices by 20–50%, depending on payer negotiations.
- Regulatory Changes: Policy initiatives aimed at reducing drug prices (e.g., importation, negotiation) can further influence future pricing.
Price Projection Scenarios
| Scenario | Time Frame | Assumptions | Price Trend | Expected Price Range |
|---|---|---|---|---|
| Optimistic (Brand stability) | 1-2 Years | Patent renewal, strong demand | Slight increase or stabilization | $XX,XXX – $XX,XXX |
| Moderate (Patent expiry approaching) | 1 Year | Entry of generics, increased competition | Sharp decline | $X,XXX – $X,XXX |
| Pessimistic (Fast generic entry & policy changes) | 6-12 Months | Rapid generic launch, price controls | Rapid decline | <$X,XXX |
Note: Precise numerical projections depend on the actual indication, patent information, and competitive landscape, which warrants real-time market intelligence for refined estimates.
Regulatory and Market Risks
Key risks include:
- Patent Litigation: Potential delays in generic entry.
- Regulatory Policies: Price controls or importation policies could suppress prices.
- Market Adoption: Slower-than-expected uptake diminishes revenue potential.
- Supply Chain Disruptions: Manufacturing or distribution issues can impact availability and pricing.
Concluding Remarks
The outlook for NDC 00009-7667 reflects initial brand stability, with anticipated price erosion approaching patent expiry. Strategic stakeholders should prepare for intensified competition, especially from generics, and consider diversification into adjunct markets or indication expansions to mitigate declining revenues. Companies with flexible manufacturing and robust pipeline development will be best positioned amidst evolving market conditions.
Key Takeaways
- Market Size & Demand: Driven by indication prevalence, with a growing focus on specialty medications.
- Pricing Trends: Currently high but poised for decline within 1-3 years as patent exclusivity lapses.
- Competitive Dynamics: Entry of biosimilars/generics will pressure prices downward.
- Strategic Implications: Innovator companies should plan for patent cliffs and diversify portfolios; investors should monitor regulatory shifts and patent statuses.
- Pricing Optimization: Rebate programs, negotiate discounts proactively, and consider alternative formulations or indications for revenue preservation.
FAQs
1. What factors primarily influence the price of NDC 00009-7667?
Patent status, competition from generics or biosimilars, regulatory policies, and market demand significantly influence its pricing trajectory.
2. How soon can we expect generic versions of this drug?
Typically, generic entry occurs within 1-3 years following patent expiration, contingent on patent litigation outcomes and regulatory approvals.
3. What impact will upcoming patent expiration have on the drug’s price?
Patent expiration usually leads to a sharp price reduction due to increased competition, often by 50-80%.
4. Are there opportunities to extend the commercial lifespan of this drug?
Yes, through patent extensions, new indications, formulation improvements, and partnerships targeting niche markets.
5. How do rebate programs influence the net price for this medication?
Rebate programs can significantly lower net costs, often by 20-50%, affecting overall market profitability.
References
- U.S. Food and Drug Administration (FDA) National Drug Code Directory.
- IQVIA. (2022). Healthcare Data and Market Trends.
- Evaluate Pharma. (2022). Global Oncology Market Report.
- Generic Pharmaceutical Association (GPhA). Market Dynamics and Patent Expiry Analysis.
- Centers for Medicare & Medicaid Services (CMS). Drug Pricing and Rebate Policies.
(Note: The specific numerical values, such as current prices, expected patent expiration dates, and market sizes, are placeholders pending precise data retrieval from industry sources and official regulatory filings.)
More… ↓
